Home / Stocks / EIKN

EIKN insider trading

Eikon Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$51.1M
Buys · last 90 days
0 · $0
Most recent buy
2026-02-09

Cluster buy detected

3 insiders bought EIKN within a short window (2026-02-04→2026-02-06), $51.1M in total — cluster score 44/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-02-09Column Group IV GP, LPcluster
10% owner
Bought2,117,760$18.00$38.1M
2026-02-06Foresite Capital Fund IV, L.P.cluster
10% owner
Bought55,555$18.00$1000k
2026-02-06FRAZIER KENNETH Ccluster
Director
Bought111,111$18.00$2.0M
2026-02-06Wolfe Joshcluster
Director · 10% owner
Bought277,776$18.00$5.0M
2026-02-06Wolfe Joshcluster
Director · 10% owner
Bought277,776$18.00$5.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Column Group IV GP, LP10% owner1$38.1M
Wolfe JoshDirector · 10% owner2$10.0M
FRAZIER KENNETH CDirector1$2.0M
Foresite Capital Fund IV, L.P.10% owner1$1000k

See EIKN on the chart

Every insider buy and sell for EIKN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.